2022 was a year of growth for InSingulo

We are thrilled to announce the unprecedented growth of InSingulo during 2022. Over the past year, we have achieved significant milestones in expanding our capabilities and team, which we believe will propel us towards greater success in the years to come.

One of the most notable achievements is the addition of several key personnel to our team. We have recently hired a Business Development Manager, who brings a wealth of experience in commercializing scientific discoveries, and two Biophysicists who have an exceptional track record in developing new technologies for drug discovery. We also welcomed a molecular biologist and a Surface Chemist, whose expertise will significantly enhance our research capabilities. In addition, we have appointed a Head of Software Development, who will lead the development of new software tools to accelerate drug discovery.

Moreover, to support our growth, we have engaged a team of experienced professionals on a consultancy basis. We are pleased to have a CFO who has extensive experience in finance and accounting, an Instrument Manager who brings a wealth of experience in operating and maintaining advanced laboratory equipment, and a Marketing Manager who has a proven track record in developing and executing marketing strategies.

To accommodate our growing team and research needs, we have significantly expanded our laboratory facilities at the AstraZeneca BioVentureHub. Our new space features state-of-the-art facilities, including two fully functional instrument units, which will enable us to accelerate our research and development efforts. Furthermore, we have fully upgraded our digital infrastructure, ensuring that our team has access to the latest software and tools to support their work.

Our growth and expansion are a testament to our commitment to developing innovative solutions that will advance the field of drug discovery. We are confident that our expanded team and new facilities will enable us to continue to deliver groundbreaking results in our research and development efforts.

In conclusion, we are excited about the progress we have made and are committed to building on this momentum. We are confident that our expanded team and new facilities will enable us to continue to deliver groundbreaking results in our research and development efforts. We look forward to sharing more updates with you as we continue on this journey of growth and innovation.